PCSK1 and Obesity: To date, 17 individuals in 15 families have been reported to have disease-causing mutations in PCSK1. Thus enteroendocrine cell dysfunction governs the early clinical phenotype, while malabsorption may actually lessen the severity of the obesity that develops at later ages.